about
Recent Developments of Liposomes as Nanocarriers for Theranostic Applications.Improving the clinical impact of biomaterials in cancer immunotherapy.Relationships between Poly(ethylene glycol) Modifications on RNA-Spherical Nucleic Acid Conjugates and Cellular Uptake and Circulation Time.Cross-Linked Micellar Spherical Nucleic Acids from Thermoresponsive Templates.The Sequence-Specific Cellular Uptake of Spherical Nucleic Acid Nanoparticle Conjugates.Nanoparticle-Based Manipulation of Antigen-Presenting Cells for Cancer Immunotherapy.Designing DNA nanodevices for compatibility with the immune system of higher organismsSchlafen 4-expressing myeloid-derived suppressor cells are induced during murine gastric metaplasia.The delivery of therapeutic oligonucleotidesAccelerating the Translation of Nanomaterials in Biomedicine.Oligonucleotide therapeutics: chemistry, delivery and clinical progress.Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook.DNA-Mediated Cellular Delivery of Functional Enzymes.Cellular processing and destinies of artificial DNA nanostructures.Synthetic nanovaccines for immunotherapy.Rethinking cancer nanotheranostics.Enhancing the Stability and Immunomodulatory Activity of Liposomal Spherical Nucleic Acids through Lipid-Tail DNA Modifications.Immunoengineering with biomaterials for enhanced cancer immunotherapy.Drug-Loaded Polymeric Spherical Nucleic Acids: Enhancing Colloidal Stability and Cellular Uptake of Polymeric Nanoparticles through DNA Surface-Functionalization.Conjugation Chemistry-Dependent T-Cell Activation with Spherical Nucleic Acids.Liposomal Spherical Nucleic Acids for Regulating Long Noncoding RNAs in the Nucleus.Highly Stable, Ultra-Small Polymer-Grafted Nanobins (usPGNs) with Stimuli-Responsive Capability.Synthesis and Assembly of Click-Nucleic-Acid-Containing PEG-PLGA Nanoparticles for DNA Delivery.PLGA Spherical Nucleic Acids.Molecular spherical nucleic acids.Patent highlights August-September 2016.C-Type lectin receptor(s)-targeted nanoliposomes: an intelligent approach for effective cancer immunotherapy.Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune Potentiation
P2860
Q26744835-75646366-4AF9-4C52-A07F-0640662FD0C3Q26766267-6751393D-5855-4A42-A498-181E3D2A9924Q33713687-C4FCC113-50CA-4D09-8DED-EF671F91DA03Q33859321-F91BFD60-6DDB-4D20-96D2-7A944807709BQ36028957-6EC9E00C-ECDB-47F0-B0DE-1C25FBFA244CQ36269694-ACF2D60B-1EF1-4136-9ADE-F9BF657CE480Q36888146-B0EB6E79-AEBE-4873-A301-9E4C229E0527Q37137917-D94983B9-6D0D-4A40-B23E-609FB1935A13Q37210936-3E8697FB-4E4F-4C56-8218-6BD34CAD9DB2Q37581374-33B16F13-6614-47FD-81CC-D3534CB68572Q38618638-B18FF105-11CD-4C0E-9521-43DAD469DCA5Q38677432-4EEB509F-1505-4F97-85BD-61E83A69A912Q38818127-205604B6-9F36-4953-AE35-8877F67BBC20Q38818821-BEB7FDF3-2027-47D0-9ABD-2A1F2082FA28Q40280801-C9C450A0-E607-44F2-9EFA-715F02933CD7Q42640884-4996DEC5-6BAB-490C-AD49-AB36D24468ABQ47262881-D4D61B1A-B921-4935-B50B-1C50672D2319Q47732542-7F018027-BC26-4374-AA8C-5B9617EA2466Q48173886-92AF5D5E-C21A-4A64-83C3-7B5C6E4D90C3Q48195387-5EF8552E-DD6C-4157-A4A0-9DD8726BBD7DQ48887906-6D256AF1-3BD8-4962-84BB-E5957CCFA87FQ49499411-180ABB2B-292B-4F86-A7A6-216E22158C2DQ50921323-D3FC967A-9536-4BA1-8C9C-955B38CF0371Q53072183-0DB04274-64CC-43D6-B7C9-8F2A56C377C2Q53697044-77A02C3B-E1C9-4D3D-8ACD-E31431432C59Q54076993-B69754FC-1770-4757-955B-41F518CD63DBQ54139494-C0E854E6-3BC5-4ADC-9154-956348E97E31Q56993652-BCEC620C-3C71-4E34-999B-C4BC38F99482
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Immunomodulatory spherical nucleic acids.
@ast
Immunomodulatory spherical nucleic acids.
@en
type
label
Immunomodulatory spherical nucleic acids.
@ast
Immunomodulatory spherical nucleic acids.
@en
prefLabel
Immunomodulatory spherical nucleic acids.
@ast
Immunomodulatory spherical nucleic acids.
@en
P2093
P2860
P356
P1476
Immunomodulatory spherical nucleic acids.
@en
P2093
Aleksandar F Radovic-Moreno
Christopher C Mader
Clayton H Rische
David A Walker
Liangliang Hao
Merideth Burkhart
Natalia Chernyak
Richard S Kang
Sagar Anantatmula
Sergei M Gryaznov
P2860
P304
P356
10.1073/PNAS.1502850112
P407
P50
P577
2015-03-16T00:00:00Z